JAKARTA – BGI Genomics and Naleya Genomics were honored to participate in the 3rd Indonesian Society of Human Genetics (InaSHG) Conference, where we contributed to insightful discussions and advancements in human genetics and precision medicine.
During the conference, Dr. Peng Zhiyu, Vice President of BGI Genomics, delivered an insightful presentation titled “Thalassemia Screening and Therapy.” In his talk, Dr. Peng Zhiyu shared genomics innovative approaches to preventing thalassemia through genetic testing. His insights emphasized the transformative potential of early screening in improving patient outcomes and the role of gene therapy as a future treatment option for thalassemia.
As part of our contribution to breaking the chain of thalassemia in Indonesia, Naleya Genomics offers the NALEYA®-THALASEQTM service, powered by BGI Genomics, for thalassemia genetic testing. NALEYA®-THALASEQTM is the most comprehensive thalassemia genetic testing service in Indonesia, capable of detecting more than 500 variants related to alpha and beta thalassemia using NGS + PCR Multiplex technology, making it affordable and accessible for all Indonesians.
Additionally, Jeremy Cao, General Manager of BGI Genomics Southeast Asia, shared groundbreaking perspectives on how BGI Genomics’ advanced precision medicine services are reshaping disease prevention strategies, aligning with the mission of “Omics for All.”
Naleya Genomics laboratory, powered by BGI Genomics technology, now offers localized genomics services to enhance the quality of healthcare in Indonesia, in line with our mission of “Omics for Indonesia.” Our lab provides NIFTY® a Non-Invasive Prenatal Testing (NIPT), NALEYA®-THALASEQTM a thalassemia genetic testing, NALEYA® HPV as HPV DNA testing for early detection of cervical cancer, COLOTECT® for early detection of colorectal cancer, and NALEYA® PGT-A a comprehensive Preimplantation Genetic Testing for Aneuploidies (PGT-A) to increase the success rate of IVF. In the future, Naleya Genomics laboratory will offer additional testing options.
A special highlight of the conference was the visit from His Excellency Budi Gunadi Sadikin, Indonesia’s Minister of Health, to the BGI Genomics and Naleya Genomics booth. We are deeply grateful for his recognition of our ongoing efforts to combat thalassemia in Indonesia.
BGI Genomics and Naleya Genomics remain committed to advancing human genetics and precision medicine, working collaboratively to improve health outcomes for individuals and communities.
